Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs

Liver International

Volumn 27, Issue 3, 2007, Pages 368-372

  Yoshimoto, Tsuyoshi ^a   Kotoh, Kazuhiro ^a   Horikawa, Yuki ^a   Kohjima, Motoyuki ^a   Morizono, Shusuke ^a   Yamashita, Shinsaku ^a   Enjoji, Munechika ^a   Nakamuta, Makoto ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Complication; Hepatocellular carcinoma; Over ablation; RFA

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BLOOD VOLUME; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIUM LESION; FEMALE; HISTOPATHOLOGY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NECROSIS; LIVER VEIN; MATHEMATICAL ANALYSIS; NONHUMAN; PATHOGENESIS; PORTAL VEIN BLOOD FLOW; RADIOFREQUENCY ABLATION; SWINE;

ANIMALS; BLOOD FLOW VELOCITY; CATHETER ABLATION; FEMALE; LIVER; NECROSIS; PORTAL VEIN; REGIONAL BLOOD FLOW; SUS SCROFA;

EID: 33947289589     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01454.x     Document Type: Article

References (18)

1. Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 2005; 29: 1364-73.
2. Poon RT, Ng KK, Lam CM, et al. Learning curve for radiofrequency ablation of liver tumors: Prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004; 239: 441-9.
3. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: From percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62 (Suppl. 1): 64-8.
4. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-9.
5. Raut CP, Izzo F, Marra P, et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005; 12: 616-28.
6. Luo BM, Wen YL, Yang HY, et al. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma. World J Gastroenterol 2005; 11: 6277-80.
7. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127: S159-66.
8. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003; 226: 441-51.
9. Chen MH, Yang W, Yan K, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 2005; 11: 6395-401.
10. Jansen MC, van Duijnhoven FH, van Hillegersberg R, et al. Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg 2005; 92: 1248-54.
11. Moumouh A, Hannequin J, Chagneau C, et al. A tamponade leading to death after radiofrequency ablation of hepatocellular carcinoma. Eur Radiol 2005; 15: 234-7.
12. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004; 239: 450-8.
13. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-65.
14. Shen P, Fleming S, Westcott C, Challa V. Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: Effect of the Pringle maneuver. J Surg Oncol 2003; 83: 36-41.
15. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: Correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229: 409-14.
16. Kayacetin E, Efe D, Dogan C. Portal and splenic hemodynamics in cirrhotic patients: Relationship between esophageal variceal bleeding and the severity of hepatic failure. J Gastroenterol 2004; 39: 661-7.
17. Lencioni R, Della Pina C, Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 2005; 30: 401-8.
18. Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005; 11: 1117-26.